Promising results from the phase 1 portion of a multi-center phase 1/2 clinical trial (ZUMA-1…
adminApril 4, 2017
New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's…
adminFebruary 13, 2017
The BCCA Provincial Systemic Therapy Program approves Bendamustine With Rituximab for Previously Untreated CLL or…
adminJanuary 13, 2017
On September 29, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On July 19, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for VENCLEXTA™ (venetoclax), a…
adminDecember 16, 2016
Lymphoma Canada is pleased to award its 2016 Research Fellowship to Dr. Anja Mottok, a…
adminAugust 15, 2016
